← Back to Search

Behavioural Intervention

Standard Vestibular Rehabilitation for Vestibular Disorder (APV Trial)

N/A

Recruiting

Led By Brooke Klatt, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18-years and older with symptomatic complaints of dizziness and/or imbalance and a medical diagnosis of unilateral vestibular hypofunction

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8-weeks

Awards & highlights

APV Trial Summary

This trial will look at how certain factors affect the daily activities and participation of people with vestibulopathy. They will collect information before and after the participants undergo vestibular rehabilitation.

Who is the study for?

This trial is for adults over 18 with dizziness or imbalance due to a diagnosed unilateral vestibular disorder. Participants must be able to move around in the community, have decent vision (20/40 or better with glasses), and good sensation in their feet.Check my eligibility

What is being tested?

The study is testing how well vestibular rehabilitation helps people with balance disorders improve their daily activities and participation. It involves assessing patients before and after they complete the rehab program.See study design

What are the potential side effects?

Vestibular rehabilitation typically doesn't involve drugs, so drug side effects aren't expected. However, some may experience temporary increased dizziness or balance issues as they adjust to exercises.

APV Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and have been diagnosed with balance issues due to one-sided inner ear problems.

APV Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8-weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8-weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dizziness Handicap Inventory

Late-life Function and Disability Instrument

APV Trial Design

1Treatment groups

Experimental Treatment

Group I: Standard Vestibular RehabilitationExperimental Treatment1 Intervention

All participants will receive standard vestibular rehabilitation

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,723 Previous Clinical Trials

16,343,106 Total Patients Enrolled

3 Trials studying Vestibular Disorder

205 Patients Enrolled for Vestibular Disorder

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

330 Previous Clinical Trials

178,421 Total Patients Enrolled

2 Trials studying Vestibular Disorder

512 Patients Enrolled for Vestibular Disorder

Brooke Klatt, PhDPrincipal InvestigatorAssistant Professor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"Per information from clinicaltrials.gov, this investigation is actively seeking participants. It was initially listed on 1/1/2024 and most recently modified on 2/20/2024."

Answered by AI

Does this medical study include individuals who are at least 70 years of age in their patient recruitment?

"Individuals aged 18 to 100 years are eligible for enrollment in this clinical study."

Answered by AI

How many individuals are currently enrolled in this medical study?

"Indeed, the information available on clinicaltrials.gov confirms the ongoing recruitment of participants for this particular medical investigation. Initially shared with the public on January 1st, 2024, and subsequently updated recently on February 20th, 2024. The study aims to enroll a total of 50 patients from one designated site."

Answered by AI